Inflammation is a key precursor to metabolic syndrome, increasing risks of hypertension, visceral obesity, and dyslipidemia, which can damage pancreatic β-cells and reduce insulin secretion, contributing to T2D. This evidence concerns the gene INS and hypertensive disorder.